awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33574602-8B44E81C-3FBF-4373-BA67-7DA1B70EB200
Q33574602-8B44E81C-3FBF-4373-BA67-7DA1B70EB200
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33574602-8B44E81C-3FBF-4373-BA67-7DA1B70EB200
High rates of early treatment discontinuation in hepatitis C-infected US veterans.
P2860
Q33574602-8B44E81C-3FBF-4373-BA67-7DA1B70EB200
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33574602-8B44E81C-3FBF-4373-BA67-7DA1B70EB200
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8fd6ba0385408107d9e1fe331a4f20b77243225
P2860
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.